A trade and tariffs war between the US and EU would have wide-ranging consequences, affecting economies, industries, consumers, and international relations on both sides of the Atlantic. Let’s break this down into key areas based on economic principles, historical examples, and current dynamics as of February 26, 2025. Economic Impacts Higher Costs for ConsumersTariffs are essentially taxes on imported goods, which increase prices for consumers. If the US imposes tariffs on EU exports—like cars, machinery, or pharmaceuticals—and the EU retaliates with tariffs on US goods—like agricultural products or tech—the cost of these items rises. For example, European carmakers exported over €90 billion worth of vehicles to the US in 2023, and a US tariff could add thousands to the price of each car sold there. Similarly, American farmers could see their exports—like soybeans or poultry—face higher EU tariffs, pushing up… 

The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released a position statement today emphasizing that limited access to quality clinical laboratory services is impeding children’s health, and that action must be taken to address this significant problem. In particular, the statement calls on Congress to increase funding for programs such as the Children’s Health Insurance Program and newborn screening in order to create a more equitable healthcare landscape for children. High quality clinical laboratory testing plays a critical role in the diagnosis and management of pediatric patients. However, numerous significant barriers currently stand between children and access to effective tests. One of the biggest is the rising cost of healthcare and a lack of price transparency, which can make essential laboratory tests unaffordable for many families. Even for families with insurance, high-deductible plans lead to significant out-of-pocket expenses,… 

Forscher entdecken in Immunzellen aus Gliomtumoren vier koordinierte Genexpressionprogramme, darunter zwei, die zu einer Resistenz gegen eine Immuntherapie führen könnten. Die Immuntherapie hat die Behandlung vieler Krebsarten revolutioniert, doch die Behandlung von Hirntumoren wie Gliomen bleibt besonders schwierig, unter anderem weil sie die Immunreaktionen stark unterdrücken. Neue Erkenntnisse von Forschern des Broad Institute of MIT und Harvard sowie des Dana-Farber Cancer Institute (DFCI) könnten dazu beitragen, Immuntherapien gegen Hirntumore wirksamer zu machen. Das Team analysierte fast 200.000 einzelne Immunzellen, sogenannte myeloide Zellen, aus Tumorproben von Patienten mit Gliomen, der häufigsten und aggressivsten Art von primärem Hirnkrebs. In einer neuen Studie in Nature fanden die Forscher vier Genexpressions-„Programme“ – Sätze von Genen mit koordinierter Aktivität –, die das Immunsystem entweder unterdrücken oder aktiver machen. Sie stellten auch fest, dass Patienten, die mit Dexamethason, einem häufigen Medikament für Hirnkrebspatienten, behandelt wurden, Anzeichen…